Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection

C Locht, JF Papin, S Lecher, AS Debrie… - The Journal of …, 2017 - academic.oup.com
C Locht, JF Papin, S Lecher, AS Debrie, M Thalen, K Solovay, K Rubin, N Mielcarek
The Journal of Infectious Diseases, 2017academic.oup.com
Evidence suggests that the resurgence of pertussis in many industrialized countries may
result from the failure of current vaccines to prevent nasopharyngeal colonization by
Bordetella pertussis, the principal causative agent of whooping cough. Here, we used a
baboon model to test the protective potential of the novel, live attenuated pertussis vaccine
candidate BPZE1. A single intranasal/intratracheal inoculation of juvenile baboons with
BPZE1 resulted in transient nasopharyngeal colonization and induction of immunoglobulin …
Abstract
Evidence suggests that the resurgence of pertussis in many industrialized countries may result from the failure of current vaccines to prevent nasopharyngeal colonization by Bordetella pertussis, the principal causative agent of whooping cough. Here, we used a baboon model to test the protective potential of the novel, live attenuated pertussis vaccine candidate BPZE1. A single intranasal/intratracheal inoculation of juvenile baboons with BPZE1 resulted in transient nasopharyngeal colonization and induction of immunoglobulin G and immunoglobulin A to all antigens tested, while causing no adverse symptoms or leukocytosis. When BPZE1-vaccinated baboons were challenged with a high dose of a highly virulent B. pertussis isolate, they were fully protected against disease, whereas naive baboons developed illness (with 1 death) and leukocytosis. Total postchallenge nasopharyngeal virulent bacterial burden of vaccinated animals was substantially reduced (0.002%) compared to naive controls, providing promising evidence in nonhuman primates that BPZE1 protects against both pertussis disease and B. pertussis infection.
Oxford University Press